Drug intelligence / Profile preview

BMS-986435

Development stage
Phase 2
Lead developer
Bristol Myers Squibb
Modality
Small Molecules
Administration
Oral
01

Overview

BMS-986435 (also known as MYK-224 and HCM-2) is an investigational small molecule drug developed for cardiovascular conditions. It acts as a cardiac myosin modulator and is being studied primarily for the treatment of heart failure with preserved ejection fraction (HFpEF) and hypertrophic cardiomyopathy. The drug aims to improve heart muscle function by modulating the activity of cardiac myosin, potentially offering a novel therapeutic approach distinct from existing treatments that do not target this pathway directly. Clinical trials are ongoing to evaluate its safety, tolerability, pharmacokinetics, and efficacy in both patients with HFpEF and those with symptomatic hypertrophic cardiomyopathy[1][3][4][5].

Other names
BMS-986435BMS986435BMS 986435MYK-224MYK224MYK 224HCM-2HCM2HCM 2
02

Targets

MYH7 (Cardiac beta-myosin heavy chain)

Beyond the preview

Go deeper on BMS-986435.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on BMS-986435.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call